Coronavirus Disease 2019. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: Hospitalized children with COVID-19 are 3 months to 14 years old and will receive daily vitamin D with a dose of 1000 international units. Intervention 2: Control g
Sponsors
Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Months to 14 Years
Inclusion criteria
Inclusion criteria: Children suffering from coronavirus disease 2019 (COVID-19) 3 months to 14 years old hospitalization children in hospital
Exclusion criteria
Exclusion criteria: Children that have a history of hepatitis disease Children that have malabsorption disorder Children that are undergoing chemotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of vitamin D consumption on the fever. Timepoint: Assess the severity of the Coronavirus disease 2019 at the beginning of the study (before the intervention) and every 24 hours after starting cunsumtion of vitamin D as daily. Method of measurement: Mercury thermometer device.;The effect of vitamin D consumption on the respiratory distress. Timepoint: Assess the severity of the Coronavirus disease 2019 at the beginning of the study (before the intervention) and every 24 hours after starting consumption of vitamin D as daily. Method of measurement: Pulse oximeter device.;The effect of vitamin D consumption on hospitalization. Timepoint: Assess the severity of the Coronavirus disease 2019 at the beginning of the study (before the intervention) and every 24 hours after starting consumption of vitamin D as daily. Method of measurement: Number of days of hospitalization for treatment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHouman Hashemian
Guilan University of Medical Sciences
Outcome results
None listed